Dr. Shyam S.d. Rao, MD, PhD

Dr. Rao practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Rao's NPI, 1265559694, was assigned on March 22, 2007. Dr. Rao graduated from UC Irvine School of Medicine in 2005. Dr. Rao's New York license number on file is 257544.

Dr. Rao's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Rao's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Rao is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Rao to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rao practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rao's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rao is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Rao's licenses on file in 3 states: New York, California and Missouri.

Dmand AI lists bone cancer radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Rao treats.

CMS data shows 2,552 Medicare services from Dr. Rao across 16 procedure codes in 2024, for 309 Medicare patients. Medicare paid $184,922 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 309 Medicare patients who saw Dr. Rao in 2024. The largest group is 65 to 74, with 161 patients. 66% of them have high cholesterol, and 65% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rao's median patient age at 67, with 33% women.

In 2024, Dr. Rao wrote 209 Medicare Part D claims for 66 patients. 82% of them were for generic drugs. CMS names the drug for 145 of them, across 7 drugs with 11 or more claims each, at $2,495 in total drug cost. In 2023, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rao for performance year 2024, reported as part of a group. Dr. Rao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rao as offering telehealth.

Dmand AI links 22 papers to Dr. Rao, published from 2012 to 2023. 2014 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Chemoradiotherapy. Dr. Rao has published most often in Am J Clin Oncol. Dr. Rao's most frequent co-authors are Nancy Lee, MD, Richard J. Wong, MD and Arnaud F. Bewley, MD.

Dmand AI links Dr. Rao to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

CMS Open Payments shows 8 general payments to Dr. Rao from 6 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 42% of the total. Varian Medical Systems, Inc. paid the most, $405.

Dr. Rao graduated from UC Irvine School of Medicine in 2005.

Dr. Rao is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.